Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes

References

• American Diabetes Association: All about diabetes. Available at: http://www.diabetes.org/about-diabetes.jsp [Last accessed 5 August 2008]
   Google Scholar
• American Diabetes Association. Economic costs of diabetes in the US in 2007. Diabetes Care 2008;31:596-615
   PubMed Web of Science ®Google Scholar
• Tabak AG, Tamas G, Zgibor J, et al. Targets and reality: a comparison of health care indicators in the U.S. (Pittsburgh Epidemiology of Diabetes Complications Study) and Hungary (DiabCare Hungary). Diabetes Care 2000;23:1284-9
   PubMed Web of Science ®Google Scholar
• DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA 2003;289:2254-64
   PubMed Web of Science ®Google Scholar
• Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2008;31:173-5
   PubMed Web of Science ®Google Scholar
• Petrak F, Stridde E, Leverkus F, et al. Development and validation of a new measure to evaluate psychological resistance to insulin treatment. Diabetes Care 2007;30:2199-204
   PubMed Web of Science ®Google Scholar
• Morris AD, Boyle DI, McMahon AD, et al., for the DARTS/MEMO Collaboration (Diabetes Audit and Research in Tayside Scotland; Medicines Monitoring Unit). Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. Lancet 1997;350:1505-10
   PubMed Web of Science ®Google Scholar
• Harris MI. Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care 2000;23:754-8
   PubMed Web of Science ®Google Scholar
• de Sonnaville JJ, Snoek FJ, Colly LP, et al. Well-being and symptoms in relation to insulin therapy in type 2 diabetes. Diabetes Care 1998;21:919-24
   PubMed Web of Science ®Google Scholar
• Alberti G. The DAWN (Diabetes Attitudes, Wishes and Needs) study. Pract Diabetes Int 2002;19:22-4
   Google Scholar
• Peyrot M, Rubin RR, Lauritzen T, et al. Psychosocial problems and barriers to improved diabetes management: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabet Med 2005;22:1379-85
   PubMed Web of Science ®Google Scholar
• Hamilton JG. Needle phobia: a neglected diagnosis. J Fam Pract 1995;41:169-75
   PubMed Web of Science ®Google Scholar
• Leslie CA, Satin-Rapaport W, Matheson RN, et al. Psychological insulin resistance: a missed diagnosis? Diabetes Spectrum 1994;7:52-7
   Google Scholar
• Peyrot M, Mathews DR, Snoek FJ, et al. An international study of psychological resistance to insulin use among persons with diabetes. Diabetologia 2003;46 Suppl. 2:A89
   PubMed Web of Science ®Google Scholar
• Nakar S, Yitzhaki G, Rosenberg R, et al. Transition to insulin in type 2 diabetes: family physicians’ misconception of patients’ fears contributes to existing barriers. Journal of Diabetes and its Complications 2007;21:220-6
   PubMed Web of Science ®Google Scholar
• Polonsky WH, Jackson RA. What's so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Clinical Diabetes 2004;22:147-50
   Google Scholar
• Skovlund SE, van der Ven N, Pouwer F, et al. Appraisal of insulin treatment in type 2 diabetes patients with and without previous experience of insulin therapy (Abstract). Diabetes 2003;52:A419
   Google Scholar
• Rubino A, McQuay LJ, Gough SC, et al. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with type 2 diabetes: a population-based analysis in the UK. Diabet Med 2007;24:1412-8
   PubMed Web of Science ®Google Scholar
• Polonsky WH, Fisher L, Guzman S, et al. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care 2005;28:2543-5
   PubMed Web of Science ®Google Scholar
• Yki-Jarvinen H, Juurinen L, Alvarsson M, et al. INITIATE (INITiate Insulin by Aggressive Titration and Education). A randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups. Diabetes Care 2007;30:1364-9
   Google Scholar
• Bogatean MP, Hancu N. People with type 2 diabetes facing the reality of starting insulin therapy: factors involved in psychological insulin resistance. Practical Diabetes Int 2004;21:247-52
   Google Scholar
• Martinez L, Consoli SM, Monnier L, et al. Studying the hurdles of insulin prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire. Health Qual Life Outcome 2007;5:53
   PubMed Web of Science ®Google Scholar
• Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obesity 2002;26(Suppl. 3):s18-s24
   Google Scholar
• Meece J. Dispelling myths and removing barriers about insulin in type 2 diabetes. Diabetes Educat 2006;32:S9-18
   PubMed Web of Science ®Google Scholar
• Mollema ED, Snoek FJ, Heine RJ, et al. Phobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screening. Diabet Med 2001;18:671-4
   PubMed Web of Science ®Google Scholar
• Goebel-Fabbri AE, Fikkan J, Franko DL, et al. Insulin restriction and associated morbidity and mortality in women with type 1 diabetes. Diabetes Care 2008;31:415-9
   PubMed Web of Science ®Google Scholar
• Bienvenu OJ, Eaton WW. The epidemiology of blood-injection-injury phobia. Psychol Med 1998;28:1129-36
   PubMed Web of Science ®Google Scholar
• Larkin ME, Capasso VA, Chen C, et al. Measuring psychological insulin resistance: barriers to insulin use. Diabetes Educat 2008;34:511-17
   PubMed Web of Science ®Google Scholar
• Zambanini A, Newson RB, Maisey M, et al. Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract 1999;46:239-46
   PubMed Web of Science ®Google Scholar
• Mollema ED, Snoek FJ, Heine RJ. Assessment of perceived barriers in self-care of insulin-requiring diabetic patients. Patient Educ Counsel 1996;29:277-81
   PubMed Web of Science ®Google Scholar
• Mollema ED, Snoek FJ, Ader HJ, et al. Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing: psychological comorbidity and general well-being. J Psychosom Res 2001;51:665-72
   PubMed Web of Science ®Google Scholar
• Snoek FJ, Skovlund SE, Pouwer F. Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes. Health Qual Life Outcome 2007;5:69
   PubMed Web of Science ®Google Scholar
• Metsch J, Tillil H, Kobberling J, et al. On the relation among psychological distress, diabetes-related health behavior, and level of glycosylated hemoglobin in type I diabetes. Int J Behav Med 1995;2:104-17
   PubMed Web of Science ®Google Scholar
• Berlin I, Bisserbe J, Eiber R, et al. Phobic symptoms, particularly the fear of blood and injury, are associated with poor glycemic control in type I diabetic adults. Diabetes Care 1997;20:176-8
   PubMed Web of Science ®Google Scholar
• Bradley C, Gilbride CJB. Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine. Diabetes Obes Metabol 2008;10(Suppl. 2):50-65
   PubMedGoogle Scholar
• Brod M, Christensen T, Bushnell D. Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes. Qual Life Res 2007;16:1053-63
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group (DCCT). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53
   PubMed Web of Science ®Google Scholar
• Koro CE, Bowlin SJ, Bourgeois N, et al. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes. Diabetes Care 2004;27:17-20
   PubMed Web of Science ®Google Scholar
• Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-31
   PubMed Web of Science ®Google Scholar
• Diabetes Control and Complications Trial (DCCT) Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial. Am J Cardiol 1995;75:894-903
   PubMed Web of Science ®Google Scholar
• Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-17
   PubMed Web of Science ®Google Scholar
• Lustman PJ. Anxiety disorders in adults with diabetes mellitus. Psychiatr Clin North Am 1988;11:419-32
   PubMed Web of Science ®Google Scholar
• Mayou R, Peveler R, Davies B, et al. Psychiatric morbidity in young adults with insulin-dependent diabetes mellitus. Psychol Med 1991;1:639-45
   Google Scholar
• Cappelleri JC, Cefalu WT, Rosenstock J, et al. Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen. Clin Ther 2002;24:552-64
   PubMed Web of Science ®Google Scholar
• Testa MA, Simonson DC. Satisfaction and quality of life with premeal inhaled versus injected insulin in adolescents and adults with type 1 diabetes. Diabetes Care 2007;30:1399-405
   PubMed Web of Science ®Google Scholar
• Henry RR, Mudaliar SR, Howland III WC , et al. Inhaled insulin using the AERx insulin diabetes management system in healthy and asthmatic subjects. Diabetes Care 2003;26:764-9
   PubMed Web of Science ®Google Scholar
• Harsch IA. Inhaled insulins: their potential in the treatment of diabetes mellitus. Treat Endocrinol 2005;4:131-8
   PubMedGoogle Scholar
• Stockl K, Ory C, Vanderlpas A, et al. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Curr Med Res Opin 2007;23:133-46
   PubMed Web of Science ®Google Scholar
• Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients’ fears and hopes about insulin therapy. Diabetes Care 1997;20:292-8
   PubMed Web of Science ®Google Scholar
• Snoek FJ, Mollema ED, Heine RJ, et al. Development and validation of the diabetes fear of injecting and self-testing questionnaires (D-FISQ): first findings. Diabet Med 1997;14:871-6
   PubMed Web of Science ®Google Scholar
• Mollema ED, Snoek EJ, Pouwer F, et al. Diabetes fear of injecting and self-testing questionnaire. Diabetes Care 2000;23:765-9
   PubMed Web of Science ®Google Scholar